本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Mersana Therapeutics Inc.

29.08
0.0000
成交量:- -
成交額:2,077.17萬
市值:1.45億
市盈率:-2.06
高:29.08
開:29.08
低:29.08
收:29.08
52周最高:36.25
52周最低:5.21
股本:499.88萬
流通股本:375.34萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-14.0861
每股收益(LYR):-14.1163
淨資產收益率:-505.14%
總資產收益率:-36.27%
市淨率:-2.44
市盈率(LYR):-2.06

資料載入中...

2025/01/10

重要事件披露

Form 8-K - Current report
2024/12/19

重要事件披露

Form 8-K - Current report
2024/11/15

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/10/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/06/11

重要事件披露

Form 8-K - Current report
2024/05/17

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report